Palvella Therapeutics's total assets for Q1 2024 were $6.39M, a decrease of -83.47% from the previous quarter. PVLA total liabilities were $12.66M for the fiscal quarter, a 6.21% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.